Uncategorized

Here’s a very thoughtful summary of the current RSV market, which is getting more crowded and more interesting by the minute. Michale Gibney reports on Merck’s new monoclonal antibody for young children and how it fits into what is becoming a rather competitive landscape. Gives you a nice perspective on vaccines and monoclonal antibodies for

This article from Science on Moderna’s new RSV vaccine illustrates the challenges facing developers of RSV vaccines for children As you know the RSV vaccine construct was used for the book Bad Pharma as we knew it was a needed vaccine being currently developed by numerous manufacturers. RSV vaccines have been difficult to develop since

The respiratory syncytial virus (RSV)  is a common, highly contagious virus, that typically causes mild symptoms similar to the common cold.  In older adults and young children, especially those with underlying conditions, RSV can cause severe infections of the lungs.  The two currently licensed vaccines – AREXVY and ABRYSVO – are indicated for the prevention

Sid, our protagonist, suffers from bipolar disorder, or manic depressive illness.  This disease, while both very serious a debilitating, is also quite fascinating.  Why should too mood swings – mania and depression – that appear to be polar opposites of one another, be connected by a single disease state?  What are your thoughts on this? Who do you

Much of the conflict in this novel concerns the issue of who should make a clinical decision when a patient who volunteered for a clinical trial received an investigational drug that didn’t work.  When there is a licensed drug or vaccine to which the failed investigational drug is being compared, it is reasonable to consider